Skip to content

A Randomized Controlled Trial for 'Huoxue Tongluo Decoction' in Treating Erectile Dysfunction of Blood Stasis and Kidney Deficiency

A Randomized Controlled Trial for 'Huoxue Tongluo Decoction' in Treating Erectile Dysfunction of Blood Stasis and Kidney Deficiency

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002469
Enrollment
Unknown
Registered
2019-07-15
Start date
2019-07-09
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male erectile dysfunction

Interventions

Sponsors

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1 meet the diagnostic criteria of impotence (erectile dysfunction) Western medicine; 2 meet the diagnostic criteria of impotence-blood stasis and kidney deficiency syndrome; 3 male, aged 20 to 69 years, have the same conditions, normal sexual desire; 4 IIEF-5= 12 weeks; 6 people who have voluntarily signed informed consent.

Exclusion criteria

Exclusion criteria: 1 Allergic constitution and those who are allergic to experimental drugs; 2 Patients with renal cancer, bladder tuberculosis, and urinary calculi; 3 Combined with other malignant tumor patients; 4 Patients with blood system diseases, coagulopathy and autoimmune diseases; 5 Combined with severe cardiovascular disease, cerebrovascular disease, hematopoietic system disease, neuropathic patients; 6 Participated in other clinical researchers 3 months before the trial. For the above 6 exclusion criteria, as long as one of the criteria is met, the exclusion criteria are met and need to be excluded.

Design outcomes

Primary

MeasureTime frame
international index of erectile function, IIEF-5;

Secondary

MeasureTime frame
TCM syndrome score;

Countries

China

Contacts

Public ContactJisheng Wang

Department of Andrology, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing China

houdejisheng@sina.com+86 18134048843

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026